1. Generalized Cost-Effectiveness Analysis of Pharmaceutical Interventions for Primary Prevention of Cardiovascular Disease in Thailand 
Panrasri Khonputsa, PhD, Lennert J. Veerman, MD, PhD, Melanie Bertram, PhD, Stephen S. Lim, PhD, Nathorn Chaiyakunnaphruk, PhD, Theo Vos, PhD 
Value in Health Regional Issues 
Volume 1, Issue 1, Pages (May 2012)
DOI: /j.vhri
Copyright © 2012 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions

2. Fig. 1
Cardiovascular disease prevention model. CVD, cardiovascular disease; IHD, ischemic heart disease.
Value in Health Regional Issues 2012 1, 15-22DOI: ( /j.vhri )
Copyright © 2012 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions

3. Fig. 2
Intervention pathway of lifetime DALYs averted and total costs associated with the ideal mix of blood pressure- and cholesterol-lowering drugs for cardiovascular disease prevention in Thailand. BP, blood pressure; DALY, disability-adjusted life-years.
Value in Health Regional Issues 2012 1, 15-22DOI: ( /j.vhri )
Copyright © 2012 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions